- Home
- SCOR vs CALC Comparison
SCOR vs CALC Comparison
Compare SCOR & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- CALC
- Stock Information
- Founded
- SCOR 1999
- CALC 2011
- Country
- SCOR United States
- CALC United States
- Employees
- SCOR N/A
- CALC N/A
- Industry
- SCOR Business Services
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- CALC Health Care
- Exchange
- SCOR Nasdaq
- CALC Nasdaq
- Market Cap
- SCOR 25.6M
- CALC 20.9M
- IPO Year
- SCOR 2007
- CALC N/A
- Fundamental
- Price
- SCOR $4.88
- CALC $1.91
- Analyst Decision
- SCOR Buy
- CALC Strong Buy
- Analyst Count
- SCOR 2
- CALC 3
- Target Price
- SCOR $10.75
- CALC $16.33
- AVG Volume (30 Days)
- SCOR 12.5K
- CALC 33.2K
- Earning Date
- SCOR 05-06-2025
- CALC 05-14-2025
- Dividend Yield
- SCOR N/A
- CALC N/A
- EPS Growth
- SCOR N/A
- CALC N/A
- EPS
- SCOR N/A
- CALC N/A
- Revenue
- SCOR $354,961,000.00
- CALC N/A
- Revenue This Year
- SCOR $4.17
- CALC N/A
- Revenue Next Year
- SCOR $2.74
- CALC N/A
- P/E Ratio
- SCOR N/A
- CALC N/A
- Revenue Growth
- SCOR N/A
- CALC N/A
- 52 Week Low
- SCOR $4.59
- CALC $1.43
- 52 Week High
- SCOR $15.69
- CALC $6.02
- Technical
- Relative Strength Index (RSI)
- SCOR 41.84
- CALC 56.52
- Support Level
- SCOR $4.54
- CALC $1.86
- Resistance Level
- SCOR $5.37
- CALC $2.04
- Average True Range (ATR)
- SCOR 0.41
- CALC 0.14
- MACD
- SCOR 0.03
- CALC 0.05
- Stochastic Oscillator
- SCOR 26.98
- CALC 64.79
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.